Terbinafin Axapharm 125 mg
Terbinafin Axapharm 125 mg is a medicine authorised by Swissmedic under authorisation number 58452. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 August 2007 and the authorisation is valid without a time limit. ATC code D01BA02 places the medicine in the group Antifungals for dermatological use.
| Authorisation number | 58452 |
|---|---|
| Name | Terbinafin Axapharm 125 mg |
| Full name | Terbinafin Axapharm 125 mg, Tabletten |
| Authorisation holder | axapharm ag |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D01BA02 |
| First authorisation | 02 August 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Terbinafin Axapharm 125 mg, Tabletten | B | 02 August 2007 |
| 2 | Terbinafin Axapharm 250 mg, Tabletten | B | 02 August 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | D01BA02 | 08.06.0. | B |
| 3 | 14 | Tablette(n) | D01BA02 | 08.06.0. | B |
| 5 | 28 | Tablette(n) | D01BA02 | 08.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Terbinafin Axapharm 125 mg authorised in Switzerland?
Yes. Terbinafin Axapharm 125 mg is authorised by Swissmedic under authorisation number 58452, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Terbinafin Axapharm 125 mg have?
Terbinafin Axapharm 125 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Terbinafin Axapharm 125 mg?
The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.